Your account is not claimed yet. You can sign up with ORCID to claim your account.

Chun-Hui Lan (Chunhui Lan)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Venues

Therapeutic advances in gastroenterology

Helicobacter

Gut

This page only lists publications with an associated author ORCID identifier.

Publications

Jie Hu, Hao Mei, Na-Yun Su, Wen-Jing Sun, De-Kui Zhang, Li-Lin Fan, Ping He, Jie Pan, Xing-Wei Wang, Pei-Ying Zou, Yu-Xiang Liu, Yan Guo, Chun-Hui Lan
Eradication rates of Helicobacter pylori in treatment-naive patients following 14-day vonoprazan-amoxicillin dual therapy: A multicenter randomized controlled trial in China. Helicobacter (2023)
Na-Yun Su, Qing Shi, Hao Mei, Jie Hu, Yu-Xiang Liu, Han-Ning Liu, Heng-Qi Liu, Yan Guo, Xing-Wei Wang, Chun-Hui Lan
Efficacy and safety of vonoprazan-based dual therapy and esomeprazole-based dual therapy in eradicating primary Helicobacter pylori infection: A propensity score matching analysis. Helicobacter (2023)
Zhiqiang Song, Ye Chen, Hong Lu, Zhirong Zeng, Wei-Hong Wang, Xiaofeng Liu, Guoxin Zhang, Qin Du, Xingzhou Xia, Changping Li, Shulin Jiang, Ting Wu, Peiyuan Li, Shuixiang He, Yin Zhu, Guiying Zhang, Jianming Xu, Yan Li, Lijuan Huo, Chun-Hui Lan, Yinglei Miao, Haixing Jiang, Ping Chen, Lijun Shi, Biguang Tuo, Dekui Zhang, Kui Jiang, Jiangbin Wang, Ping Yao, Xiaoxi Huang, Shaoqi Yang, Xuehong Wang, Li-Ya Zhou
Diagnosis and treatment of Helicobacter pylori infection by physicians in China: A nationwide cross-sectional study. Helicobacter 27 (3) (2022)
Zhe Zhao, Pei-Ying Zou, Na-Yun Su, Yan Guo, Xing-Wei Wang, Jing-Tao Zhao, Hao Mei, Qing Shi, Bin Wang, Dong-Feng Chen, Chun-Hui Lan
High-dose dual therapy versus culture-based susceptibility-guided therapy as a rescue regimen for Helicobacter pylori infection: a randomized controlled trial. Therapeutic advances in gastroenterology 15 (2022)
Hao Mei, Yan Guo, Jing-Tao Zhao, Jun Yang, Wen-Jing Sun, De-Kui Zhang, Ping He, Gang Shi, Na-Yun Su, Ran Han, Chun-Hui Lan
Efficacy and safety of high-dose esomeprazole and amoxicillin dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori infection: a multicenter, randomized controlled clinical trial. Therapeutic advances in gastroenterology 15 (2022)
Hao Mei, Yan Guo, Jing-Tao Zhao, Jun Yang, Wen-Jing Sun, De-Kui Zhang, Ping He, Gang Shi, Na-Yun Su, Ran Han, Chun-Hui Lan
Efficacy and safety of high-dose esomeprazole and amoxicillin dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori infection: a multicenter, randomized controlled clinical trial. Therapeutic advances in gastroenterology 15 (2022)
Zhe Zhao, Pei-Ying Zou, Na-Yun Su, Yan Guo, Xing-Wei Wang, Jing-Tao Zhao, Hao Mei, Qing Shi, Bin Wang, Dong-Feng Chen, Chun-Hui Lan
High-dose dual therapy versus culture-based susceptibility-guided therapy as a rescue regimen for Helicobacter pylori infection: a randomized controlled trial. Therapeutic advances in gastroenterology 15 (2022)
Song-Ze Ding, Yi-Qi Du, Hong Lu, Wei-Hong Wang, Hong Cheng, Shi-Yao Chen, Min-Hu Chen, Wei-Chang Chen, Ye Chen, Jing-Yuan Fang, Heng-Jun Gao, Ming-Zhou Guo, Ying Han, Xiao-Hua Hou, Fu-Lian Hu, Bo Jiang, Hai-Xing Jiang, Chun-Hui Lan, Jing-Nan Li, Yan Li, Yan-Qing Li, Jie Liu, You-Ming Li, Bin Lyu, You-Yong Lu, Ying-Lei Miao, Yong-Zhan Nie, Jia-Ming Qian, Jian-Qiu Sheng, Cheng-Wei Tang, Fen Wang, Hua-Hong Wang, Jiang-Bin Wang, Jing-Tong Wang, Jun-Ping Wang, Xue-Hong Wang, Kai-Chun Wu, Xing-Zhou Xia, Wei Fen Xie, Yong Xie, Jian-Ming Xu, Chang-Qing Yang, Gui-Bin Yang, Yuan Yuan, Zhi-Rong Zeng, Bing-Yong Zhang, Gui-Ying Zhang, Guo-Xin Zhang, Jiangzhong Zhang, Zhen-Yu Zhang, Peng-Yuan Zheng, Yin Zhu, Xiu-Li Zuo, Li-Ya Zhou, Nong-Hua Lyu, Yun-Sheng Yang, Zhao-Shen Li, null null
Chinese Consensus Report on Family-Based Helicobacter pylori Infection Control and Management (2021 Edition). Gut (2021)
Pei-Ying Zou, Jie Hu, Jing-Tao Zhao, Zhe Zhao, Hao Mei, Jing Yang, Yang-Jie Zhu, Yi Zhang, Chun-Hui Lan
10-Day and 14-day high-dose dual therapy for the treatment of Helicobacter pylori: A propensity score matching analysis. Helicobacter 26 (5) (2021)
Yang-Jie Zhu, Yi Zhang, Ting-Yi Wang, Jing-Tao Zhao, Zhe Zhao, Jian-Ru Zhu, Chun-Hui Lan
High dose PPI-amoxicillin dual therapy for the treatment of Helicobacter pylori infection: a systematic review with meta-analysis. Therapeutic advances in gastroenterology 13 (2020)

Chun-Hui Lan.css-eqlu8i{font-size:small;padding-left:4px;} (Chunhui Lan)

Publication Activity (10 Years)

Top Topics

Top Venues

Chun-Hui Lan (Chunhui Lan)